(FM) Inmunología
Departamento académico
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (8)
2016
-
Cancer Treatment with Anti-PD-1/PD-L1 Agents: Is PD-L1 Expression a Biomarker for Patient Selection?
Drugs, Vol. 76, Núm. 9, pp. 925-945
-
Perspectives in immunotherapy: Meeting report from the "Immunotherapy Bridge", Napoli, December 5th 2015
Journal for ImmunoTherapy of Cancer, Vol. 4, Núm. 1
2015
-
Consensus nomenclature for CD8+ T cell phenotypes in cancer
OncoImmunology, Vol. 4, Núm. 4
-
Future perspectives in melanoma research: Meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014
Journal of Translational Medicine, Vol. 13, Núm. 1
-
PD-L1 expression as a potential predictive biomarker
The Lancet Oncology
2014
-
Awareness and understanding of cancer immunotherapy in Europe
Human Vaccines and Immunotherapeutics, Vol. 10, Núm. 7, pp. 1828-1835
-
Classification of current anticancer immunotherapies
Oncotarget, Vol. 5, Núm. 24, pp. 12472-12508
2011
-
Defining the critical hurdles in cancer immunotherapy
Journal of Translational Medicine